NOVEL MECHANISM OF ACTION FOR NUR77 AND ANTAGONISM BY GLUCOCORTICOIDS- A CONVERGENT MECHANISM FOR CRH ACTIVATION AND GLUCOCORTICOID REPRESSION OF POMC GENE-TRANSCRIPTION
J. Drouin et al., NOVEL MECHANISM OF ACTION FOR NUR77 AND ANTAGONISM BY GLUCOCORTICOIDS- A CONVERGENT MECHANISM FOR CRH ACTIVATION AND GLUCOCORTICOID REPRESSION OF POMC GENE-TRANSCRIPTION, Journal of steroid biochemistry and molecular biology, 65(1-6), 1998, pp. 59-63
Whereas orphan nuclear receptors of the Nur77 (NGFI-B) subfamily were
previously known to act on transcription as monomers or as heterodimer
s with RXR, we have recently shown that Nur77 homodimers potently acti
vate transcription upon interaction with a novel palindromic response
element, the NurRE. In fact, reporter plasmids containing the NurRE re
spond to physiological stimuli in conditions where the NBRE, a binding
site for Nur77 monomers, does not. Nur77 and its related receptors we
re shown to be important mediators for control of apoptosis induced by
the T-cell receptor, and they also mediate the effect of the hypothal
amic hormone CRH on transcription of the pituitary pro-opiomelanocotin
(POMC) gene. In both systems, glucocorticoids antagonize the stimulat
ory effects of Nur77 on transcription by a mechanism that involves pro
tein:protein interactions. Thus, the Nur77 signalling pathway appears
to be a point of convergence for stimulatory signals and glucocorticoi
d repression in both endocrine and lymphoid systems. (C) 1998 Elsevier
Science Ltd. All rights reserved.